EcoDrugPlus

Presenilin 2

Ensembl ID : ENSDLEG00000001858
Gene Symbol: PSEN2
1 Cross references
206 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSDLEG00000002605
Gene Symbol: PSENEN
1 Cross references
185 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSDLEG00000019262
Gene Symbol: PGR
3 Cross references
194 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSDLEG00000007421
Gene Symbol: PTGDR
3 Cross references
118 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSDLEG00000001501
Gene Symbol: PTGDR2
3 Cross references
205 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSDLEG00000021895
Gene Symbol: PTGER1
3 Cross references
237 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSDLEG00000007415
Gene Symbol: PTGER2
3 Cross references
244 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSDLEG00000021453
Gene Symbol: PTGER3
1 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSDLEG00000008354
Gene Symbol: PTGER4
3 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSDLEG00000016018
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSDLEG00000004041
Gene Symbol: PTGIR
1 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSDLEG00000000675
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).